2-(2-(Cyclopropylmethoxy)-6-fluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95+%, 1g

3-(Benzyloxy)-4-bromobenzaldehyde, 95.0%, 500mg

2-(3,3-DIFLUOROCYCLOBUTYL)ACETALDEHYDE, 95.0%, 1g

2-(Tert-butyl)-1,3,4-oxadiazole, 98%, 5g

Ethyl Acetoacetate, 98.0%, 500g

1-Benzyl-4-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)piperazine, 98+%, 100mg

Methyl 1-Methyl-1,2,5,6-tetrahydropyridine-3-carboxylate hydrobromide, 97.0%, 10g

N-(5-Bromo-2-methoxypyridin-3-yl)-2,4-difluorobenzenesulfonamide, 95.0%, 5g

2-(tert-Butoxycarbonyl)isoindoline-1-carboxylic acid, 95.0%, 250mg

(4S,4'S)-4,4'-Diisopropyl-1,1'-di-p-tolyl-4,4',5,5'-tetrahydro-1H,1'H-2,2'-biimidazole, 98%, 250mg

2-{[4-(methylsulfonyl)phenyl]amino}-1,3-thiazole-4-carboxylic acid, 95.0%, 500mg

1-N-Boc-4-(2-Furfurylmethylamino)piperidine, 95.0%, 1g

Flacon à col étroit fluoré, 2000 ml, 2 pièce(s)